News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|July 1, 1999

BEHAVIOR: ASK THE EXPERTS

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

New sunscreen ingredient clears FDA for the first time since the 1990s

New sunscreen ingredient clears FDA for the first time since the 1990s

ByMorgan Ebert, Executive Editor

June 9th 2026

FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy

FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy

ByMorgan Ebert, Executive Editor

June 9th 2026

New evidence backs pediatric flu vaccination efficacy as CDC drops it from childhood schedule | Image Credit: © N Lawrenson/peopleimages.com - stock.adobe.com.

New evidence backs pediatric flu vaccination efficacy as CDC drops it from childhood schedule

ByMorgan Ebert, Executive Editor

June 9th 2026

ALYFTREK phase 3 data support pediatric CFTR modulator submissions | Image Credit: © Feng - stock.adobe.com.

ALYFTREK phase 3 data support pediatric CFTR modulator submissions

ByMorgan Ebert, Executive Editor

June 8th 2026

Earlier egg introduction guidelines linked to measurable decline in infant egg allergy prevalence | Image Credit: © LIGHTFIELD STUDIOS - stock.adobe.com.

Earlier egg introduction guidelines linked to measurable decline in infant egg allergy prevalence

ByMorgan Ebert, Executive Editor

June 8th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy

New sunscreen ingredient clears FDA for the first time since the 1990s

FDA expands marstacimab (HYMPAVZI) approval to children ages 6–11 and hemophilia patients with inhibitors

New evidence backs pediatric flu vaccination efficacy as CDC drops it from childhood schedule

Earlier egg introduction guidelines linked to measurable decline in infant egg allergy prevalence